Literature DB >> 24173827

THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?

Marie Fabritius1, Bernard Favrat, Haithem Chtioui, Giovanni Battistella, Jean-Marie Annoni, Monique Appenzeller, Kim Dao, Eleonora Fornari, Estelle Lauer, Jean-Frédéric Mall, Philippe Maeder, Patrice Mangin, Christian Staub, Christian Giroud.   

Abstract

Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the patient, administrative, and legal consequences will be different if the subject is a regular or an occasional cannabis smoker. To this end, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) has been proposed as a criterion to help to distinguish between these two groups of users. However, to date this indicator has not been adequately assessed under experimental conditions. We carried out a controlled administration study of smoked cannabis with a placebo. Cannabinoid levels were determined in whole blood using tandem mass spectrometry. Significantly high differences in THCCOOH concentrations were found between the two groups when measured during the screening visit, prior to the smoking session, and throughout the day of the experiment. Receiver operating characteristic (ROC) curves were determined and two threshold criteria were proposed in order to distinguish between these groups: a free THCCOOH concentration below 3 µg/L suggested an occasional consumption (≤ 1 joint/week) while a concentration higher than 40 µg/L corresponded to a heavy use (≥ 10 joints/month). These thresholds were tested and found to be consistent with previously published experimental data. The decision threshold of 40 µg/L could be a cut-off for possible disqualification for driving while under the influence of cannabis. A further medical assessment and follow-up would be necessary for the reissuing of a driving license once abstinence from cannabis has been demonstrated. A THCCOOH level below 3 µg/L would indicate that no medical assessment is required.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  THCCOOH; cannabis; heavy use; occasional use; whole blood

Mesh:

Substances:

Year:  2013        PMID: 24173827     DOI: 10.1002/dta.1581

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  8 in total

1.  Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.

Authors:  Ryan Vandrey; Evan S Herrmann; John M Mitchell; George E Bigelow; Ronald Flegel; Charles LoDico; Edward J Cone
Journal:  J Anal Toxicol       Date:  2017-03-01       Impact factor: 3.367

2.  Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography-mass spectrometry.

Authors:  Cristina Sempio; Jelena Klawitter; Matthew Jackson; Francesca Freni; Ryan Shillingburg; Kent Hutchison; L Cinnamon Bidwell; Uwe Christians; Jost Klawitter
Journal:  Anal Bioanal Chem       Date:  2021-04-05       Impact factor: 4.142

3.  Psychiatric and medical management of marijuana intoxication in the emergency department.

Authors:  Quan M Bui; Scott Simpson; Kimberly Nordstrom
Journal:  West J Emerg Med       Date:  2015-04-09

4.  Long-term effects of cannabis on brain structure.

Authors:  Giovanni Battistella; Eleonora Fornari; Jean-Marie Annoni; Haithem Chtioui; Kim Dao; Marie Fabritius; Bernard Favrat; Jean-Frédéric Mall; Philippe Maeder; Christian Giroud
Journal:  Neuropsychopharmacology       Date:  2014-03-17       Impact factor: 7.853

5.  Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report.

Authors:  Franziska Gaunitz; Hilke Andresen-Streichert
Journal:  Int J Legal Med       Date:  2021-12-18       Impact factor: 2.791

6.  Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac Myocytes.

Authors:  Ayse Orme Merve; Pola Sobiecka; Vytautas Remeškevičius; Luke Taylor; Lili Saskoy; Scott Lawton; Ben P Jones; Ahmed Elwakeel; Francesca E Mackenzie; Elena Polycarpou; Jason Bennett; Brian Rooney
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

7.  Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on-line solid phase extraction.

Authors:  Priska Frei; Stephanie Frauchiger; Eva Scheurer; Katja Mercer-Chalmers-Bender
Journal:  Drug Test Anal       Date:  2022-02-28       Impact factor: 3.234

8.  Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.

Authors:  Jennifer A Manuzak; Toni M Gott; Jay S Kirkwood; Ernesto Coronado; Tiffany Hensley-McBain; Charlene Miller; Ryan K Cheu; Ann C Collier; Nicholas T Funderburg; Jeffery N Martin; Michael C Wu; Nina Isoherranen; Peter W Hunt; Nichole R Klatt
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 20.999

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.